Further progress in HER2-directed therapy

Lancet Oncol. 2012 Jan;13(1):2-3. doi: 10.1016/S1470-2045(11)70388-6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / metabolism*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Inflammation / pathology*
  • Receptor, ErbB-2 / metabolism*

Substances

  • Biomarkers, Tumor
  • ERBB2 protein, human
  • Receptor, ErbB-2